Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
36 hedge funds and large institutions have $7.52M invested in Lumos Pharma, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 0 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
9% more funds holding
Funds holding: 33 → 36 (+3)
7% less capital invested
Capital invested by funds: $8.05M → $7.52M (-$535K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$145K |
| 2 |
Two Sigma Advisers
New York
|
+$96.4K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.4K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1.71K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Blackstone Inc
New York
|
-$482K |
| 2 |
Renaissance Technologies
New York
|
-$17.4K |
| 3 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$13.6K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$10.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $5K | -$1.22K | -358 | -19% |
|
|
WFA
27
West Financial Advisors
Des Moines,
Iowa
| $2.49K | – | – | – |
|
28
Morgan Stanley
New York
| $1.06K | +$715 | +210 | +172% |
|
29
Group One Trading
Chicago,
Illinois
| $470 | – | – | – |
|
|
CCMW
30
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
| $318 | – | – | – |
|
31
UBS Group
Zurich,
Switzerland
| $235 | +$252 | +74 | New |
|
32
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $130 | – | – | – |
|
33
JP Morgan Chase
New York
| $119 | +$10 | +3 | +9% |
|
|
LOIP
34
Live Oak Investment Partners
Austin,
Texas
| $35 | – | – | – |
|
|
GRP
35
Global Retirement Partners
San Rafael,
California
| $31 | – | – | – |
|
36
Qube Research & Technologies (QRT)
London,
United Kingdom
| $9 | – | – | – |
|
37
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$133 | -39 | -33% |
|
LUMO Hedge Fund Activity: Q4 2023 in Review
36 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q4 2023, worth a combined $7.52M — down 6.6% from $8.05M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new LUMO positions and 0 closed out — a net gain of 3 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $145K. The largest seller was Blackstone Inc, cutting an estimated $482K.
- 36 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q4 2023, up from 33 in Q3 2023.
- Funds reported $7.52M of Lumos Pharma, Inc. Common Stock stock for Q4 2023, down 6.6% quarter-over-quarter.
- 3 funds opened new Lumos Pharma, Inc. Common Stock positions in Q4 2023 and 0 closed out, a net change of +3 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q4 2023 was Two Sigma Investments, an estimated $145K added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q4 2023 was Blackstone Inc, an estimated $482K sold.
Based on aggregated 13F filings for Q4 2023.